Opko Health, Inc.
OPK
$1.34
-$0.05-3.60%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 151.67M | 156.81M | 149.95M | 183.64M | 173.63M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 151.67M | 156.81M | 149.95M | 183.64M | 173.63M |
| Cost of Revenue | 104.78M | 137.75M | 138.17M | 129.40M | 136.30M |
| Gross Profit | 46.89M | 19.06M | 11.78M | 54.23M | 37.33M |
| SG&A Expenses | 53.80M | 59.60M | 59.09M | 67.03M | 98.20M |
| Depreciation & Amortization | 19.53M | 19.44M | 19.86M | 20.34M | 20.43M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 205.19M | 216.79M | 217.12M | 216.78M | 280.91M |
| Operating Income | -53.52M | -59.98M | -67.17M | -33.14M | -107.28M |
| Income Before Tax | 41.43M | -162.52M | -73.38M | 34.97M | 48.42M |
| Income Tax Expenses | 19.80M | -14.08M | -5.77M | 20.95M | 23.53M |
| Earnings from Continuing Operations | 21.63M | -148.44M | -67.61M | 14.03M | 24.89M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.63M | -148.44M | -67.61M | 14.03M | 24.89M |
| EBIT | -53.52M | -59.98M | -67.17M | -33.14M | -107.28M |
| EBITDA | -30.78M | -36.95M | -43.68M | -9.10M | -83.11M |
| EPS Basic | 0.03 | -0.19 | -0.10 | 0.02 | 0.04 |
| Normalized Basic EPS | -0.05 | -0.13 | -0.07 | 0.13 | -0.11 |
| EPS Diluted | 0.03 | -0.19 | -0.10 | 0.02 | 0.03 |
| Normalized Diluted EPS | -0.05 | -0.13 | -0.07 | 0.09 | -0.07 |
| Average Basic Shares Outstanding | 777.15M | 788.01M | 671.58M | 676.79M | 694.62M |
| Average Diluted Shares Outstanding | 779.92M | 788.01M | 671.58M | 951.84M | 998.36M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |